Warrant Exercise

FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  

                                 6 AUGUST 2007                                 

Exercise of Warrants

Finsbury Worldwide Pharmaceutical Trust PLC (the 'Company') announces that
following receipt of notices to exercise Warrants at an exercise price of 464p
on the exercise date of 31 July 2007, the Company has allotted and issued as
fully paid 14,687 new Ordinary shares in the Company under the General Block
Listing.

Following allotment, the issued share capital of the Company will be 49,939,468
Ordinary shares and 10,758,680 Warrants. These figures may be used by
shareholders as the denominator for the calculation by which they may determine
if they are required to notify their interest in, or change to their interest
in, the Company under the FSA's Disclosure and Transparency Rules.

The outstanding Warrants are exercisable on 31 July* in each of the years 2008
and 2009 at an exercise price of 464p. Warrant Exercise Notices shall be sent
to all Warrant holders prior to commencement of the exercise period of 28 days
prior to each exercise date.

As at the close of 31 July 2007, the fully diluted Net Asset Value per Ordinary
share (assuming the exercise in full of all of the outstanding warrants at an
exercise price of 464p per warrant) was 498.22p per share, the mid market share
price per Ordinary share was 471.00p and the mid market Warrant price was
76.00p.

*or if such day is not a business day, then on the next business day

                                   - Ends -                                    

For further information, please contact:

Mark Pope Frostrow Capital LLP 020 3008 4913

Alastair Smith Frostrow Capital LLP 020 3 008 4911